Regenerative medicine may offer a new opportunity for patients with untreatable degenerative conditions. Vascugen is focused on advancing cell therapies intended to restore function in tissues where there is a loss of blood flow (‘ischemia’).
Induced pluripotent stem cell (‘iPSC’) technology offers an ideal starting point for consistent and scalable manufacture of regenerative medicine products. Our proprietary cell differentiation technology enables us to derive our unique products using this technology.